因赛集团(300781.SZ)：橙盟投资拟减持不超1%股份

Group 1 - The core point of the article is that Guangdong Chengmeng Investment Limited Partnership plans to reduce its stake in InnoCare Pharma Co., Ltd. by selling up to 1.6385 million shares, which represents 1% of the company's total share capital, starting from September 1, 2025, to September 26, 2025 [1] Group 2 - Guangdong Chengmeng Investment Limited Partnership currently holds 8,071,077 shares, accounting for 4.93% of the total share capital of InnoCare Pharma [1] - The planned reduction in shares will be executed through centralized bidding [1] - The total number of shares to be sold does not exceed 163.85 million [1]